August 2010 at the National
Telling the good from the bad and the ugly:
The challenge of evaluating pharmacophore model performance.
July 2010 at SMI
Integrating Predictive ADMET into Hit to Lead and Optimisation
March 2010 at the National ACS
in San Francisco:
Effects of torsional sampling bias on a multi-objective genetic
October 2009 at the GTCBio Conference on Partnering,
Outsourcing in San Diego CA:
Trust but Verify: Getting the
Most Out of ADME/Tox Screening.
March 2009 at the ACS National Meeting in Salt Lake City
what point does docking
morph into 3D QSAR?
November 2008 at ANNIE 2008 in St. Louis MO:
To Pareto or Not to Pareto,
That is the Question.
August 2008 at the ACS National Meeting in Philadelphia PA:
Looking for some good
June 2008 at the 8th ICCS in Noordwijkerhout, the Netherlands (Poster):
The Effect of Structural
Redundancy on Virtual Screen Performance.
April 2008 at the ACS National Meeting in New Orleans LA:
uncertainty in PLS predictivity;
sides now: An intimate
perspective on collaborations.
August 2007 at the ACS National Meeting in Boston MA:
The role of
alignment in 3D QSAR;
Validation and the downside of
the law of large numbers
June 2007 at the 4th Joint Sheffield Conference on
When Worlds Collide: Looking
for Answers to "The Alignment Problem"
March 2007 at the ACS National Meeting in Chicago IL:
knowledge-based approach to quickly generating diverse but
energetically representative ensembles of ligand conformers.
November 2006 at ANNIE 2006 in St. Louis MO:
Sex and the single GA.
October 2006 at eCheminfo Community InterAction meeting in Philadelphia
September 2006 at the ACS National Meeting in San Francisco CA:
What's a drug
designer to do?;
pharmacophoric and pharmacosteric multiplets to characterize binding
September 2005 at the ACS National Meeting in Atlanta GA:
Putting the "Structure" in
(Q)SAR into context.